Intellectual Property

  • August 20, 2024

    Feds Launch Probe Into Wi-Fi Technology Imports

    The U.S. International Trade Commission opened an investigation into a domestic semiconductor company's claims that a Chinese rival was selling Wi-Fi technology in the U.S. that infringes on its intellectual property.

  • August 20, 2024

    A Deep Dive Into Law360 Pulse's 2024 Women In Law Report

    The legal industry continues to see incremental gains for female lawyers in private practice in the U.S., according to a Law360 Pulse analysis, with women now representing 40.6% of all attorneys and 51% of all associates.

  • August 20, 2024

    These Firms Have The Most Women In Equity Partnerships

    The legal industry still has a long way to go before it can achieve gender parity at its upper levels. But these law firms are performing better than others in breaking the proverbial glass ceiling that prevents women from attaining leadership roles.

  • August 20, 2024

    Catching Up With Delaware's Chancery Court

    A nearly record-breaking attorney fee got the nod in Delaware last week, along with Chancery Court settlements involving an international private jet service and a chain of trampoline parks. New disputes involved a famous burger restaurant chain, a computer-chip maker, a now-defunct genomic science company, and a historic manor house in west London.

  • August 20, 2024

    Atty's Use Of 'Gallo' Ruffles Feathers At Competing Law Firm

    A Texas law firm says an attorney in the Lone Star State is confusing the public by using "Gallo," the Spanish word for rooster, in marketing his legal services despite the firm's trademark rights for using the word in that context.

  • August 20, 2024

    IP Duo Join Thompson Hine From Cincinnati Boutique

    Thompson Hine LLP announced Tuesday that a pair of attorneys from intellectual property boutique Wood Herron & Evans joined the firm's office in Cincinnati, Ohio.

  • August 19, 2024

    Biogen Paid To Help Curb Generic Tecfidera Sales, Says Suit

    Biogen illegally impaired competition for its multiple sclerosis drug Tecfidera by paying major pharmacy benefit managers to prioritize the brand over generics while it worked to shift the market to a different version of the medication, a multi-employer welfare plan alleged Friday.

  • August 19, 2024

    T.I. Can't Bar Witness Motivation Questions At Doll IP Retrial

    Rapper T.I. can't block MGA Entertainment from questioning his customer witnesses' motivations to testify at the upcoming intellectual property retrial over the company's L.O.L. Surprise! doll line, and he likewise is barred from raising questions of cultural appropriation in that context, a California federal judge ruled Monday.

  • August 19, 2024

    Fed. Circ. Urged To Review Dish's Fight Over Atty Fee Liability

    A technology industry group on Monday urged the full Federal Circuit to take a look at a precedential panel decision preventing Dish Network LLC from collecting fees directly from a patent litigation company's lawyer, arguing that the ruling "rips a gaping hole" in legal fee jurisprudence that would "immunize" lawyers from ever having to pay attorney fees for filing baseless patent lawsuits.

  • August 19, 2024

    Judge Suggests Atty, Firm Pay Up For Not Probing IP Claims

    A Florida lawyer who once represented former President Donald Trump and the lawyer's firm should pay $150,000 in attorney fees as a monetary sanction for failing to properly investigate patent claims before suing, a federal magistrate judge has recommended, which is far below the $684,000 the defendants in the case sought.

  • August 19, 2024

    DOJ Says No Arthrex Problem In SpaceX Hiring Bias Probe

    The U.S. Department of Justice is urging a Texas federal judge to side with the administrative law judge overseeing the immigration bias investigation against SpaceX, saying the company is using its constitutional attack against the framework of the proceeding as a distraction.

  • August 19, 2024

    NuVasive Beats Fraudulent Inducement Claim At Trial

    A Delaware federal jury has rejected a physician's claim that NuVasive Inc. fraudulently induced him to enter into a 2014 agreement related to patents he owns for spinal implant system components — but also rejected the medical device manufacturer's claim that the doctor had breached the deal by suing.

  • August 19, 2024

    Philips Drops FRAND Case After Jury Trial Canceled

    Dutch electronics giant Koninklijke Philips NV agreed to drop its patent case against a major French cellular brand on Monday, shortly after both sides agreed to cancel a jury trial in Delaware federal court that would have set the licensing rates for patents covering ways of complying with 3G and 4G telecom standards.

  • August 19, 2024

    Activision Blizzard Settles After $23.4M Patent Verdict

    Video-game developer Activision Blizzard Inc. has settled a dispute with San Francisco incubator Acceleration Bay Group Inc. after a Delaware federal jury found Activision infringed two patents with its World of Warcraft and Call of Duty games and owed $23.4 million, according to papers filed in federal court on Friday.

  • August 19, 2024

    Roku Takes Dispute Over ITC Powers To Supreme Court

    Roku is telling the U.S. Supreme Court that the U.S. International Trade Commission doesn't have the power to ban the import of patent-infringing software if those patents only have a limited connection to products on sale in the market.

  • August 19, 2024

    'Mere Speculation' Thwarts PTAB Appeal, Fed. Circ. Says

    The Federal Circuit has blocked an optical filter maker from appealing a failed Patent Trial and Appeal Board challenge to a rival's patent, ruling that the company lacked standing to appeal because it presented only "mere speculation" that it might be sued again.

  • August 19, 2024

    Isaac Hayes' Family Sues Trump For Using Song In Campaign

    The family of legendary singer-songwriter Isaac Hayes has sued Republican presidential candidate Donald Trump and his campaign for using the song "Hold On, I'm Coming" to close his events and rallies, alleging the former president does not have authorization to play it and has ignored demands that he stop.

  • August 19, 2024

    Civil Rights Activist's Name Being Stolen For Diner, Suit Says

    The fight over the name of a New Jersey diner has spilled into federal court, with the family of a former operator and Garden State civil rights icon claiming the now-owners of the building home to the eponymous "Mr. G's" can't reopen it with the same name.

  • August 19, 2024

    Fair Use Dooms Santos Suit Over Jimmy Kimmel's Prank Videos

    A New York federal judge said Monday that the fair use exception to copyright law is fatal to former U.S. Rep. George Santos' suit against ABC and Jimmy Kimmel over video clips that the late-night TV show host tricked the ex-congressman into making.

  • August 19, 2024

    Quinn Emanuel Atty Behind Google IP Win Joins Debevoise

    Debevoise & Plimpton LLP has brought on a former Quinn Emanuel Urquhart & Sullivan LLP partner to its San Francisco office, strengthening its intellectual property litigation group with an attorney who helped Google convince a federal judge last year to wipe out speaker maker Sonos' nearly $33 million jury award against Google.

  • August 19, 2024

    Latham Recruits Haynes Boone Patent Litigation Pro In Austin

    Latham & Watkins LLP announced Monday that it has bolstered its intellectual property litigation practice with a partner in Austin, Texas, who came aboard from Haynes and Boone LLP.

  • August 16, 2024

    Fed. Circ. Quells Fears Over Double-Patenting Overreach

    A recent Federal Circuit decision finding patent claims licensed by Allergan were not invalid for obviousness-type double patenting provided relief to attorneys who were concerned the court had made it easier to invalidate patents that had extended expiration dates to make up for regulatory delays.

  • August 16, 2024

    CDK's $100M Deal Puts Auto Dealer Settlements Up To $130M

    Car dealerships sought preliminary approval Friday for a $100 million class action settlement resolving claims that auto dealer data management software giant CDK Global anticompetitively locked out rival data companies, adding to the $29.5 million agreement reached previously in the sprawling litigation with CDK peer Reynolds and Reynolds.

  • August 16, 2024

    Deal Struck After Jury Clears US Well On Halliburton Patents

    U.S. Well Services LLC and Halliburton Energy Services Inc. have agreed to a settlement in principle to resolve their long-running patent infringement dispute, which has seen several patents invalidated, according to a joint motion the parties filed after a jury cleared U.S. Well of infringing three still-registered Halliburton patents.

  • August 16, 2024

    Cisco Gets Another Shot At Sinking Network Security Patent

    The Federal Circuit on Friday told the Patent Trial and Appeal Board to take another look at a ruling upholding language in a network security technology patent at the heart of Cisco Systems Inc.'s fight with a litigation outfit.

Expert Analysis

  • In Memoriam: The Modern Administrative State

    Author Photo

    On June 28, the modern administrative state, where courts deferred to agency interpretations of ambiguous statutes, died when the U.S. Supreme Court overruled its previous decision in Chevron v. Natural Resources Defense Council — but it is survived by many cases decided under the Chevron framework, say Joseph Schaeffer and Jessica Deyoe at Babst Calland.

  • Series

    After Chevron: Expect Limited Changes In USPTO Rulemaking

    Author Photo

    The U.S. Supreme Court’s recent ruling overturning Chevron deference will have limited consequences for the U.S. Patent and Trademark Office given the USPTO's unique statutory features, but it is still an important decision for matters of statutory interpretation, especially those involving provisions of the America Invents Act, say Andrei Iancu and Cooper Godfrey at Sullivan & Cromwell.

  • Fed. Circ. Skinny Label Ruling Guides On Infringement Claims

    Author Photo

    The Federal Circuit's recent decision in Amarin v. Hikma shows generic drug manufacturers must pay close attention to the statements in their abbreviated new drug application labels to put themselves in the best position in defending against an induced infringement claim, say Luke Shannon and Roshan Shrestha at Taft Stettinius.

  • How To Clean Up Your Generative AI-Produced Legal Drafts

    Author Photo

    As law firms increasingly rely on generative artificial intelligence tools to produce legal text, attorneys should be on guard for the overuse of cohesive devices in initial drafts, and consider a few editing pointers to clean up AI’s repetitive and choppy outputs, says Ivy Grey at WordRake.

  • USPTO Disclaimer Rule Would Complicate Patent Prosecution

    Author Photo

    The U.S. Patent and Trademark Office's proposed changes to terminal disclaimer practice could lead to a patent owner being unable to enforce a valid patent simply because it is indirectly tied to a patent in which a single claim is found anticipated or obvious in view of the prior art, say attorneys at Sterne Kessler.

  • Series

    Boxing Makes Me A Better Lawyer

    Author Photo

    Boxing has influenced my legal work by enabling me to confidently hone the skills I've learned from the sport, like the ability to remain calm under pressure, evaluate an opponent's weaknesses and recognize when to seize an important opportunity, says Kirsten Soto at Clyde & Co.

  • Opinion

    Industry Self-Regulation Will Shine Post-Chevron

    Author Photo

    The U.S. Supreme Court's Loper decision will shape the contours of industry self-regulation in the years to come, providing opportunities for this often-misunderstood practice, says Eric Reicin at BBB National Programs.

  • When Patents As Loan Collateral Can Cost You Standing

    Author Photo

    The Federal Circuit's recent decision in Intellectual Tech v. Zebra Technologies shines a light on loan default provisions' implications for patent infringement litigation, as a default may inadvertently strip a patent owner of constitutional standing to sue over a patent pledged as collateral, say Joseph Marinelli and Suet L. Lee at Irwin IP.

  • 3 Ways Agencies Will Keep Making Law After Chevron

    Author Photo

    The U.S. Supreme Court clearly thinks it has done something big in overturning the Chevron precedent that had given deference to agencies' statutory interpretations, but regulated parties have to consider how agencies retain significant power to shape the law and its meaning, say attorneys at K&L Gates.

  • Roundup

    After Chevron

    Author Photo

    In the month since the U.S. Supreme Court overturned the Chevron deference standard, this Expert Analysis series has featured attorneys discussing the potential impact across 26 different rulemaking and litigation areas.

  • How Life Science Companies Are Approaching UPC Opt-Outs

    Author Photo

    A look at recent data shows that one year after its launch, the European Union's Unified Patent Court is still seeing a high rate of opt-outs, including from large U.S.-based life science companies wary of this unpredictable court — and there are reasons this strategy should largely remain the same, say Sanjay Murthy and Christopher Tuinenga at McAndrews Held.

  • Series

    After Chevron: Expect Few Changes In ITC Rulemaking

    Author Photo

    The U.S. Supreme Court's opinion overruling the Chevron doctrine will have less impact on the U.S. International Trade Commission than other agencies administering trade statutes, given that the commission exercises its congressionally granted authority in a manner that allows for consistent decision making at both agency and judicial levels, say attorneys at Polsinelli.

  • 6 PTAB Events To Know From The Last 6 Months

    Author Photo

    The first half of 2024 brought a flurry of Patent Trial and Appeal Board developments that should be considered in post-grant strategies, including proposed rules on discretionary denial and director review, and the first decisions of the Delegated Rehearing Panel, say attorneys at Fish & Richardson.

  • Opinion

    Atty Well-Being Efforts Ignore Root Causes Of The Problem

    Author Photo

    The legal industry is engaged in a critical conversation about lawyers' mental health, but current attorney well-being programs primarily focus on helping lawyers cope with the stress of excessive workloads, instead of examining whether this work culture is even fundamentally compatible with lawyer well-being, says Jonathan Baum at Avenir Guild.

  • FTC Focus: Competition And The Right To Repair

    Author Photo

    If the Federal Trade Commission includes commercial and industrial products as part of copyright exemptions that allow consumers to modify or repair products, then businesses and affected rights holders will need to consider copyrights' impact on infringement issues, say attorneys at Proskauer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!